Skip to main content

Advertisement

Table 3 Recommended composite disease activity assessments and prognostic assessment to guide treatment

From: A systematic review of guidelines for managing rheumatoid arthritis

Guideline Composite Disease Activity Assessments Prognostic Assessments
PAS RAPID3 CDAI SDAI DAS28 RF ACPA X-ray Erosions Poor Function Extra-Articular Disease
1. American [14] Yes Yes Yes Yes Yes      
2. APLAR [15] Yes Yes Yes Yes Yes Yes   
3. Australian [16] Yes Yes Yes   
4. Brazilian [17] Yes Yes Yes Yes Yes Yes   
5. British Columbia [18]   Yes Yes   
6. British Society For Rheumatology: Established [19]      
7. British Society For Rheumatology: Early [20]      
8. Canadian [21] Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
9. EULAR [22]    Yes Yes Yes Yes Yes Yes   
10. French [23]    Yes Yes Yes Yes Yes Yes   
11. German [24] Yes Yes Yes Yes   
12. Hong Kong [25] Yes Yes Yes Yes Yes Yes Yes Yes
13. Indian [26] Yes Yes Yes Yes Yes Yes   Yes
14. Latin American [27] Yes Yes Yes Yes Yes Yes
15. Mexican [28]    Yes Yes Yes Yes Yes    Yes
16. England [29] Yes      
17. Scotland [30] Yes Yes Yes      
18. South African [31] Yes Yes Yes Yes Yes Yes Yes
19. Spanish [32] Yes Yes Yes Yes Yes Yes Yes Yes
20. Swedish [33] Yes Yes Yes Yes Yes Yes Yes Yes
21. Treat to Target [34] Yes Yes Yes      
22. Turkish [35] Yes   Yes Yes Yes  
  1. RF Rheumatoid factor, ACPA Anti-citrullinated protein antibody